ERA and SGLT2 Inhibitor Combo Cuts Albuminuria in Chronic Kidney Disease

Daily Headlines Sunday, November 05, 2023      Today's Top Stories for Reader Reader   MEETING COVERAGE ERA and SGLT2 Inhibitor Combo Cuts Albuminuria in Chronic Kidney Disease PODCASTS Heat and Cardiovascular Death; Time-Restricted Eating or Caloric Restriction in T2D OPHTHALMOLOGY Regulation Gap Persists in OTC Eye Care Products THE BREAK ROOM Wordectomy: Guess Today's Medical Condition CME SPOTLIGHT HIV and Substance Use Disorder: An Educational Toolkit for Clinical Teams OPINION 'Money' Should Not Be a Bad Word in Medical Education OPINION For Health AI to Fulfill Its Potential, Regulation Is Paramount THE BREAK ROOM Play Today's Wordosis ADVERTISEMENT SPECIAL REPORTS Medical School on Cherokee Reservation Will Soon Send Doctors to Tribal, Rural Areas CME SPOTLIGHT Using Evidence-Based Guidelines for Personalized PrEP Initiation OPINION Medicine Has Become the McDonald's of Healthcare MEETING COVERAGE Botulinum Toxin Injection May Be an Option for Excess Saliva in Patients With ALS MEETING COVERAGE Efgartigimod Offers Hope in Chronic Inflammatory Demyelinating Polyneuropathy CME SPOTLIGHT ART and CVD: Bringing Science to Practice OPINION 'We Feel Like We're Drowning': What We Heard This Week CME SPOTLIGHT Examining the Latest Evidence for COVID-19 Vaccines CME SPOTLIGHT Charting New Territory in RSV Vaccination: International Perspectives on Protecting Older Adults CME SPOTLIGHT Managing Progression of Mild-to-Moderate COVID-19: A COVID-19 Clinical Case Challenge     Weekly Survey Concerned About Gene-Editing Therapies? FDA advisors appeared convinced that the benefits of a novel CRISPR therapy for sickle cell disease outweigh the theoretical risks for off-target gene editing   VOTE > Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. SEE ALL STORIES > Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. LEARN MORE >   © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: edwardlorilla1986.acciyo123@blogger.com Manage Email Preferences   |    Unsubscribe   |   Terms of Use   |   Privacy Policy Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011